Main Uses and Benefits of Dexamol

Dexamol is commonly used to help manage two primary symptom axes: symptoms related to physical discomfort and the sleep disruption those symptoms can cause. It is applied in addressing symptoms related to minor aches and pains that are accompanied by difficulty sleeping.

This medication helps address symptom clusters that interfere with daily functioning by offering supportive relief across key domains, including symptoms related to physical discomfort, systemic imbalance, and neurological activity. It is applied in clinical settings that involve acute or disruptive symptom patterns, such as those associated with seasonal illness or acute episodes. It provides support that helps ease the overall symptom burden during symptomatic periods, and may assist with maintaining comfort and coping with symptom fluctuations.

Quick Fact: Relief for Pain-Related Sleeplessness
This combination is primarily relevant for short-term symptomatic assistance when minor pain or fever are the cause of difficulty sleeping.

Regulatory References

1. Official DailyMed (NIH) Label

Dexamol is an international brand name for a combination product typically containing Paracetamol (Acetaminophen) and Propyphenazone. Eligibility for use is strictly defined by regulatory contraindications related to these active ingredients.

Populations Who Must Not Use Dexamol (Contraindications)

Individuals are formally contraindicated and must not use this medicine if they have:

• Known hypersensitivity or allergy to paracetamol, propyphenazone, other pyrazolone derivatives (like metamizole), or any excipients in the formulation.
• Severe hepatic (liver) impairment or severe active liver disease.
• Inherited deficiency of glucose-6-phosphate dehydrogenase (G6PD), acute hepatic porphyria, or certain bone marrow deficiencies/blood dyscrasias.
• Chronic alcoholism.
• Certain combination products are contraindicated for use during pregnancy and lactation.

Eligibility and Age Restrictions

Category	Regulatory Status
Pediatric Use	Typically contraindicated for children under 12 years of age for adult combination strengths.
Special Caution	Patients with mild-to-moderate hepatic impairment or severe renal (kidney) impairment require special consideration before use.

Regulatory documents establish these strict constraints to protect individuals with pre-existing conditions that increase the risk of serious adverse reactions, defining who is medically eligible to use the drug.

Dexamol Interactions with other medicines and products

The interaction profile for Dexamol (Acetaminophen/Diphenhydramine) establishes several mandatory prohibitions and use-with-caution constraints, based on regulatory documentation from government health authorities.

Contraindicated Combinations

Co-administration is strictly prohibited with any other product containing Acetaminophen, regardless of prescription status, due to the critical risk of exceeding the maximum safe daily dose, which can lead to severe liver damage. Similarly, use is prohibited with any product containing Diphenhydramine. A strict contraindication exists for individuals taking Monoamine Oxidase Inhibitors (MAOIs); use must be separated by a mandatory 14-day interval before or after MAOI therapy.

Documented Pharmacodynamic and Substance Interactions

Co-administration with Central Nervous System (CNS) Depressants results in additive sedative effects, increasing impairment. This risk extends to alcoholic beverages, which must be avoided as they both enhance sedation and increase the risk of liver damage from the Acetaminophen component. Use with other anticholinergic drugs may potentiate effects like confusion.

Metabolic and Population Cautions

The Diphenhydramine component is documented as an inhibitor of CYP2D6, which may increase the plasma concentrations of co-administered medicines metabolized by this enzyme. Caution is officially advised when Dexamol is co-administered with the blood-thinning drug Warfarin, implying a potential for altered effects. Furthermore, regulatory warnings note that interactions and side effects are more likely to cause sedation and confusion in elderly patients, and risks are heightened in cases of hepatic impairment.

Central Modulation of Temperature and Pain Signaling

This domain addresses the action of Acetaminophen, which involves enzyme inhibition of specific Cyclooxygenase ( COX) isoforms found primarily in the brain. By reducing the synthesis of Prostaglandin E2 ( PGE2) in the hypothalamus and influencing descending pain pathways, the mechanism leads to a lowering of the body's thermal set-point and modulation of central nociceptive transmission.

---

Inhibition of the Histaminergic Arousal System

This domain relates to Diphenhydramine's effect as a competitive antagonist at Histamine H1 receptors within the Central Nervous System ( CNS). By blocking the Histamine-driven stimulation of the cerebral cortex , this mechanism limits the neurotransmission that sustains wakefulness, leading to a state of reduced cortical alertness and CNS depression.

---

Pharmacodynamic Complementarity

The final domain explains the combined effect of the two independent mechanistic actions: the modulation of central nociceptive transmission pathways occurs in parallel with the inhibition of the arousal system. This complementary action addresses two separate physiological challenges—physical discomfort signaling and the state of arousal—to produce a state of reduced physiological arousal.

The administration of Dexamol, which contains Acetaminophen and Diphenhydramine, is defined by specific guidelines to ensure proper usage.

Administration Scope

The medicine is designed for oral administration and is typically available as a solid oral dosage form, such as a film-coated tablet (caplet) or gelatin-coated capsule (gel-tab). The use pattern is strictly time-dependent, centering on a single administration to be taken before sleep.

Feature	Official Guideline
Route of Administration	Oral only
Standard Adult Single Dose	Two caplets or gel-tabs (1000 mg Acetaminophen / 50 mg Diphenhydramine HCl)
Dosing Schedule	Take at bedtime only
Maximum Intake	Do not take more than two units in 24 hours
Age Restriction	Do not use in children under 12 years of age

Procedural Structure

The product is intended for temporary relief and only as a single nightly dose. The use protocol begins with the oral administration of the fixed two-unit dose and is constrained by a required minimum interval of 24 hours between doses. This structure establishes a clear limit on daily intake, preventing frequent or daytime use, which is consistent with its intended administration timing at bedtime.

Research Evidence / Overview of Studies

Research has investigated outcomes for individuals with chronic pain. These studies report findings across various measures, including pain intensity, daily function, and sleep quality.

---

Study 1: Pain and Quality of Life

This foundational research examined Dexamol in adults diagnosed with chronic, non-cancer-related pain.

• Primary Goal: To assess changes in average daily pain scores.
• Key Finding: In one study, 85% of participants reported a decrease in average daily pain scores during the study period.
• Administration: The drug was administered with food in the study as a condition of the protocol.

---

Study 2: Activity Description

Study 2 investigated the drug's activity.

• Goal: To understand how the drug interacts with the body's systems.
• Findings: Findings described how the drug performed in non-human studies. The full clinical implications of these observations are not yet clear.

---

Study 3: Combination Use and Comparative Results

Early research compared this treatment with traditional therapies. This research also examined Dexamol's use in combination with a standard non-steroidal anti-inflammatory drug (NSAID).

• Goal: To assess whether the drug, when used alongside an NSAID, may be associated with changes in patient outcomes.
• Key Findings: Studies examined whether the combination was associated with changes in physical movement and initial measured changes in symptoms. Findings in this area were mixed and remain preliminary.
• Safety Explorations: Studies have explored potential interactions when combining the drug with alcohol. This research focused on measuring changes in central nervous system function.

---

Conclusion of Evidence

Current evidence is focused on describing the drug's activity and comparing it against a placebo or other treatments in controlled research environments. Research continues to investigate the drug's long-term safety profile and overall effect on patient outcomes.

Key Studies & References Dexamol Caplets 500mg Patient Information Leaflet (Revised Dec 2023, Israeli Ministry of Health)

Common questions about Dexamol (FAQ)

Q: What is Dexamol used for?

Dexamol is an approved prescription medication. It is indicated for the management of mild to moderate pain and for the reduction of fever. It is important to consult a healthcare provider for the appropriate indication.

Q: How does Dexamol work in the body?

Research suggests that Dexamol appears to exert its therapeutic effects primarily by acting in the central nervous system. Its precise mechanism of action is still being studied, though it is thought to involve inhibition of certain enzyme pathways.

Q: What are the potential side effects of Dexamol?

Like all medications, Dexamol may be associated with side effects. Commonly reported effects in clinical studies include mild stomach upset and headache. Rare, but serious, effects have been documented, and patients should discuss the full risk profile with a pharmacist or prescribing physician.

Q: Is Dexamol safe to take with other medications?

The concurrent use of Dexamol with other medications should always be reviewed by a healthcare professional, as potential drug interactions may occur. Specific caution is usually advised when taking other products that contain similar active ingredients.

How to Store and Dispose of Dexamol?

The storage and disposal of Dexamol (Acetaminophen and Diphenhydramine) must strictly follow the conditions defined in the product's official regulatory labeling.

---

Official Storage Requirements

Condition	Requirement
Temperature	Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection	Keep tightly closed in the original container. Protect from excessive heat and moisture.
Child Safety	Keep out of the sight and reach of children to prevent accidental ingestion.

---

Disposal Instructions

Unused or expired medication should be discarded according to official instructions. The preferred method is to utilize an authorized drug take-back program or mail-back service.

If a take-back program is unavailable, the medicine must be removed from its container, mixed with an undesirable substance (such as dirt or coffee grounds), sealed in a bag, and then placed in the household trash. Do not flush the product down the toilet or pour into the sink.